IGHE and asthma: Despite a reduction of serum IgE in humans by 25–40% [23,174], a large clinical trial with more than 500 patients suffering from allergic asthma uncontrolled by standard therapy showed no reduction of asthma exacerbations within the 36 weeks of treatment [23].